APO RESEARCH · REPORT
Insulin API
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
Product & engineering
Understand the product.
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.
In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.
Selected research
Industry Research
Insulin API Industry Research Report 2026
Market perspective
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.
In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.
Read the full market overview
The major players in global Insulin API market include Novo Nordisk, Sanofi-Aventis, etc. The top 2 players occupy over 65% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Insulin Analogue is the main market, and occupies about 90% of the global market. Long-Acting is the main type, with a share over 40%.
Report Scope
This report quantifies the global Insulin API market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Insulin API Market by Company
Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon
Amphastar
Wockhardt
Julphar Diabetes
Torrent Pharma
Insulin API Segment by Type
Regular Human Insulin
Insulin Analogue
Insulin API Segment by Application
Fast-Acting
Premix
Long-Acting
Insulin API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Insulin API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Insulin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Insulin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Insulin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Regular Human Insulin
- Insulin Analogue
Applications
- Fast-Acting
- Premix
- Long-Acting
Companies covered
- Novo Nordisk
- Sanofi-Aventis
- Eli Lilly
- Tonghua Dongbao
- Ganlee
- United Laboratory
- Biocon
- Amphastar
- Wockhardt
- Julphar Diabetes
- Torrent Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Insulin API Market Size (2021-2032)
- 2.2.2 Global Insulin API Sales (2021-2032)
- 2.2.3 Global Insulin API Market Average Price (2021-2032)
- 2.3 Insulin API by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Regular Human Insulin
- 2.3.3 Insulin Analogue
- 2.4 Insulin API by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Fast-Acting
- 2.4.3 Premix
- 2.4.4 Long-Acting
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Insulin API Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Insulin API Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Insulin API Revenue of Manufacturers (2021-2026)
- 3.4 Global Insulin API Average Price by Manufacturers (2021-2026)
- 3.5 Global Insulin API Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Insulin API, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Insulin API, Product Type & Application
- 3.8 Global Manufacturers of Insulin API, Established Date
- 3.9 Global Insulin API Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novo Nordisk
- 4.1.1 Novo Nordisk Company Information
- 4.1.2 Novo Nordisk Business Overview
- 4.1.3 Novo Nordisk Insulin API Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novo Nordisk Insulin API Product Portfolio
- 4.1.5 Novo Nordisk Recent Developments
- 4.2 Sanofi-Aventis
- 4.2.1 Sanofi-Aventis Company Information
- 4.2.2 Sanofi-Aventis Business Overview
- 4.2.3 Sanofi-Aventis Insulin API Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi-Aventis Insulin API Product Portfolio
- 4.2.5 Sanofi-Aventis Recent Developments
- 4.3 Eli Lilly
- 4.3.1 Eli Lilly Company Information
- 4.3.2 Eli Lilly Business Overview
- 4.3.3 Eli Lilly Insulin API Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Eli Lilly Insulin API Product Portfolio
- 4.3.5 Eli Lilly Recent Developments
- 4.4 Tonghua Dongbao
- 4.4.1 Tonghua Dongbao Company Information
- 4.4.2 Tonghua Dongbao Business Overview
- 4.4.3 Tonghua Dongbao Insulin API Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Tonghua Dongbao Insulin API Product Portfolio
- 4.4.5 Tonghua Dongbao Recent Developments
- 4.5 Ganlee
- 4.5.1 Ganlee Company Information
- 4.5.2 Ganlee Business Overview
- 4.5.3 Ganlee Insulin API Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Ganlee Insulin API Product Portfolio
- 4.5.5 Ganlee Recent Developments
- 4.6 United Laboratory
- 4.6.1 United Laboratory Company Information
- 4.6.2 United Laboratory Business Overview
- 4.6.3 United Laboratory Insulin API Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 United Laboratory Insulin API Product Portfolio
- 4.6.5 United Laboratory Recent Developments
- 4.7 Biocon
- 4.7.1 Biocon Company Information
- 4.7.2 Biocon Business Overview
- 4.7.3 Biocon Insulin API Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Biocon Insulin API Product Portfolio
- 4.7.5 Biocon Recent Developments
- 4.8 Amphastar
- 4.8.1 Amphastar Company Information
- 4.8.2 Amphastar Business Overview
- 4.8.3 Amphastar Insulin API Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Amphastar Insulin API Product Portfolio
- 4.8.5 Amphastar Recent Developments
- 4.9 Wockhardt
- 4.9.1 Wockhardt Company Information
- 4.9.2 Wockhardt Business Overview
- 4.9.3 Wockhardt Insulin API Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Wockhardt Insulin API Product Portfolio
- 4.9.5 Wockhardt Recent Developments
- 4.10 Julphar Diabetes
- 4.10.1 Julphar Diabetes Company Information
- 4.10.2 Julphar Diabetes Business Overview
- 4.10.3 Julphar Diabetes Insulin API Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Julphar Diabetes Insulin API Product Portfolio
- 4.10.5 Julphar Diabetes Recent Developments
- 4.11 Torrent Pharma
- 4.11.1 Torrent Pharma Company Information
- 4.11.2 Torrent Pharma Business Overview
- 4.11.3 Torrent Pharma Insulin API Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Torrent Pharma Insulin API Product Portfolio
- 4.11.5 Torrent Pharma Recent Developments
5 Global Insulin API Market Scenario by Region
- 5.1 Global Insulin API Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Insulin API Sales by Region: 2021-2032
- 5.2.1 Global Insulin API Sales by Region: 2021-2026
- 5.2.2 Global Insulin API Sales by Region: 2027-2032
- 5.3 Global Insulin API Revenue by Region: 2021-2032
- 5.3.1 Global Insulin API Revenue by Region: 2021-2026
- 5.3.2 Global Insulin API Revenue by Region: 2027-2032
- 5.4 North America Insulin API Market Facts & Figures by Country
- 5.4.1 North America Insulin API Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Insulin API Sales by Country (2021-2032)
- 5.4.3 North America Insulin API Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Insulin API Market Facts & Figures by Country
- 5.5.1 Europe Insulin API Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Insulin API Sales by Country (2021-2032)
- 5.5.3 Europe Insulin API Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Insulin API Market Facts & Figures by Country
- 5.6.1 Asia Pacific Insulin API Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Insulin API Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Insulin API Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Insulin API Market Facts & Figures by Country
- 5.7.1 South America Insulin API Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Insulin API Sales by Country (2021-2032)
- 5.7.3 South America Insulin API Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Insulin API Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Insulin API Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Insulin API Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Insulin API Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Insulin API Sales by Type (2021-2032)
- 6.1.1 Global Insulin API Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Insulin API Sales Market Share by Type (2021-2032)
- 6.2 Global Insulin API Revenue by Type (2021-2032)
- 6.2.1 Global Insulin API Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Insulin API Revenue Market Share by Type (2021-2032)
- 6.3 Global Insulin API Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Insulin API Sales by Application (2021-2032)
- 7.1.1 Global Insulin API Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Insulin API Sales Market Share by Application (2021-2032)
- 7.2 Global Insulin API Revenue by Application (2021-2032)
- 7.2.1 Global Insulin API Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Insulin API Revenue Market Share by Application (2021-2032)
- 7.3 Global Insulin API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Insulin API Value Chain Analysis
- 8.1.1 Insulin API Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Insulin API Production Mode & Process
- 8.2 Insulin API Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Insulin API Distributors
- 8.2.3 Insulin API Customers
9 Global Insulin API Analyzing Market Dynamics
- 9.1 Insulin API Industry Trends
- 9.2 Insulin API Industry Drivers
- 9.3 Insulin API Industry Opportunities and Challenges
- 9.4 Insulin API Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst